Holen Sie sich die Stockscreener-App
324.77
1.62%
-5.36
Vorhandelsmarkt:
325.27
0.50
+0.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$330.13
Offen:
$330.8
24-Stunden-Volumen:
1.41M
Relative Volume:
0.79
Marktkapitalisierung:
$89.25B
Einnahmen:
$244.38B
Nettoeinkommen (Verlust:
$3.43B
KGV:
26.53
EPS:
12.24
Netto-Cashflow:
$8.96B
1W Leistung:
-1.35%
1M Leistung:
+2.56%
6M Leistung:
+1.42%
1J Leistung:
-7.84%
1-Tages-Spanne:
$322.11
$331.87
1-Wochen-Bereich:
$322.11
$335.16
52-Wochen-Spanne:
$262.03
$370.82
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Vergleichen Sie CI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
324.77 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
UNH
Unitedhealth Group Inc
|
425.33 | 548.34B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
406.69 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CVS
Cvs Health Corp
|
65.17 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
245.91 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
The Cigna Group (CI) Announces Executive Departure and Agreement Details - GuruFocus
Cigna Announces Termination of Executive Eric P. Palmer - TipRanks
The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend - ADVFN
Those who invested in Cigna Group (NYSE:CI) five years ago are up 94% - simplywall.st
Cigna (CI) Under Investigation for Alleged Anti-Competitive Practices in Canada - GuruFocus
Jim Cramer: Cigna (CI) Is in His Crosshairs – “The Easiest Spot” in Health Insurance - Insider Monkey
The Cigna Group (CI) Stock Price, Trades & News - GuruFocus
Jim Cramer is Bullish on These 10 Stocks - Insider Monkey
Exploring the women’s health gap - Cigna Healthcare Newsroom
Baird Adjusts Cigna Group Price Target to $362 From $388, Maintains Outperform Rating - marketscreener.com
What Does the Market Think About Cigna Group? - Benzinga
Cigna (CI) Price Target Cut by Baird Amid Policy Concerns | CI S - GuruFocus
The Cigna Group (NYSE:CI) Price Target Raised to $384.00 - Defense World
Canada launches antitrust probe into Cigna's Express Scripts unit - Reuters
Truist Securities Raises Price Target on Cigna Group to $385 From $375, Maintains Buy Rating - MarketScreener
The Cigna Group and Earvin "Magic" Johnson Team Up to Help Boys - GuruFocus
Canada Launches Probe Into Cigna’s Express Scripts Over Anti-Competitive Conduct Allegations – But Retail’s Unmoved - MSN
Cigna's Express Scripts unit faces Canada antitrust probe (CI:NYSE) - Seeking Alpha
Canada launches probe into Cigna's Express Scripts - MarketScreener
Truist Increases Price Target for Cigna (CI), Maintains Buy Rati - GuruFocus
Cigna says Canada launches probe into Express Scripts - MarketScreener
The Cigna Group and Earvin "Magic" Johnson Team Up to Help Boys & Girls Club Kids Impacted by Southern California Wildfires – Company AnnouncementFT.com - Financial Times
Cigna: Fewer Protests, More Potential (NYSE:CI) - Seeking Alpha
Guggenheim Initiates Coverage of Cigna Group (LSE:0A77) with Buy Recommendation - Nasdaq
May 30th Options Now Available For The Cigna Group (CI) - Nasdaq
Guggenheim Initiates Coverage of Cigna Group (CI) with Buy Recommendation - MSN
Magic Johnson Teams With Cigna: Inside Their $425K Push to Help California's Fire-Affected Kids - Stock Titan
Dozens Of Workers To Be Laid Off At Morris Plains Healthcare Company - Patch
AM Best confirms credit ratings for Cigna Group and subsidiaries By Investing.com - Investing.com UK
AM Best confirms credit ratings for Cigna Group and subsidiaries - Investing.com
Guggenheim Initiates Cigna Group at Buy With $384 Price Target - MarketScreener
Guggenheim sets CIGNA stock Buy rating, $384 target By Investing.com - Investing.com India
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries - Yahoo Finance
Jefferson Health Reaches New Deal With Cigna - Patch
Baron Capital Recognized with 2024 Cigna Healthy Workforce Designation™ - Business Wire
The Cigna Group (CI) Shares Gap Down to $311.72 on Apr 7 - GuruFocus
The Cigna Group Reports Strong Second Quarter 2024 Results - Seeking Alpha
Cigna Group Stock Sees RS Rating Jump To 86 - Investor's Business Daily
The Cigna Group’s First Quarter 2025 Earnings Release Details - The Malaysian Reserve
The Cigna Group's First Quarter 2025 Earnings Release Details - StreetInsider
The Cigna Group's First Quarter 2025 Earnings Release Details – Company Announcement - Financial Times
2 Reasons to Like CI (and 1 Not So Much) - Yahoo Finance
Cigna Q1 2025 Earnings: Key Details for Accessing Latest Financial Results - Stock Titan
Cigna, Aetna, Others Face Antitrust Claims Over Out-of-Network Payments - Law.com
Employers are uniquely positioned to help improve workforce mental health (podcast) - The Business Journals
May 23rd Options Now Available For The Cigna Group (CI) - Nasdaq
FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage - Benzinga
Physician Wealth Advisors Inc. Invests $730,000 in The Cigna Group (NYSE:CI) - MarketBeat
FTC puts hold on insulin lawsuit against drug middlemen - Reuters
Nomura Asset Management Co. Ltd. Buys 6,634 Shares of The Cigna Group (NYSE:CI) - MarketBeat
Mercy Health and Cigna Reach Contract Agreement - Business Journal Daily
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):